SNCE - Science 37 Holdings, Inc. Stock Price, Fair Value and News

$5.75

Market Closed

SNCE Stock Valuation Analysis

Valuation

Max Portfolio %

SNCE Price Action

SNCE RSI Chart

SNCE Stock Valuation Analysis

Valuation

Max Portfolio %

SNCE Valuation

SNCE Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

SNCE Fundamentals

SNCE Revenue

SNCE Earnings

SNCE Profitability

SNCE Investor Care

Revenue & Growth

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2023	0	66.8M	62.4M	0
2022	92.1M	98.8M	100.8M	96.4M
2021	32.7M	41.7M	50.6M	59.6M
2020	0	17.3M	20.5M	23.7M
2019	0	0	0	14.1M

Get all data in R, Python etc through our Historical Stock Data APIs

About Science 37 Holdings, Inc.

Science 37 Holdings, Inc. engages in patient-centric clinical trial activities in North Carolina. Its platform enables modern and digital approaches to clinical research, including the patient and trial investigators, nurses, coordinators, and sponsors, standardize evidence generation, and harmonize data. The company's platform also provides specialized networks of patient communities, telemedicine investigators, mobile nurses, remote coordinators, and connected devices for orchestrating clinical trials; and extensive configuration to support virtually any phase of clinical study and therapeutic area. In addition, the company licenses its proprietary hosted technology platform to various life science institutions. It serves large and mid-sized pharmaceutical companies, contract research organizations, academic institutions, and biotech companies. Science 37 Holdings, Inc. was founded in 2014 and is based in Research Triangle Park, North Carolina.

CEO	Mr. David Coman
WEBSITE	science37.com
SECTOR	Healthcare
INDUSTRY	Health Information Services
EMPLOYEES	460